CT-P13 in the treatment of rheumatoid arthritis

Yoo, DH

Yoo, DH (reprint author), Hanyang Univ, Coll Med, Hanyang Univ Hosp Rheumat Dis, 222-1 Wangsimni Ro Seongdong Gu, Seoul 04763, South Korea.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017; 13 (7): 653

Abstract

Introduction: The first biosimilar infliximab, CT-P13 infliximab-dyyb was approved in 2013 by the European Medicines Agency (EMA) and in 2016 by the U......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索